135 related articles for article (PubMed ID: 1537894)
1. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.
Washitani Y; Kuroda N; Shiraki H; Itoyama Y; Sato H; Ohshima K; Kiyokawa H; Maeda Y
J Clin Microbiol; 1992 Feb; 30(2):287-90. PubMed ID: 1537894
[TBL] [Abstract][Full Text] [Related]
2. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
[TBL] [Abstract][Full Text] [Related]
3. [Immunoreactivity of synthetic peptides, corresponding to B-cellular epitopes of human type I T-lymphotrophic virus structural proteins].
Rasuli AM; Klepikov NN; Andreev SM; Sidorova MV; Vafina MG; Seniuta NB; Pavlish OA; Syrtsev AV; Gurtsevich VE
Mol Biol (Mosk); 1993; 27(4):880-7. PubMed ID: 8361494
[TBL] [Abstract][Full Text] [Related]
4. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
[TBL] [Abstract][Full Text] [Related]
6. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
Inoue Y; Kuroda N; Shiraki H; Sato H; Maeda Y
Int J Cancer; 1992 Dec; 52(6):877-80. PubMed ID: 1459728
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
Kuroda N; Washitani Y; Shiraki H; Kiyokawa H; Ohno M; Sato H; Maeda Y
Int J Cancer; 1990 May; 45(5):865-8. PubMed ID: 2185995
[TBL] [Abstract][Full Text] [Related]
9. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
10. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
Nakamura M; Kuroki M; Kira J; Itoyama Y; Shiraki H; Kuroda N; Washitani Y; Nakano S; Nagafuchi S; Anzai K
J Neuroimmunol; 1991 Dec; 35(1-3):167-77. PubMed ID: 1955565
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.
Papsidero LD; Dittmer RP; Vaickus L; Poiesz BJ
J Clin Microbiol; 1992 Feb; 30(2):351-8. PubMed ID: 1371516
[TBL] [Abstract][Full Text] [Related]
12. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
13. [Cross reactivity and amino acid structural homology of immunodominant peptide fragments of structural viruses from the human retroviruses HTLV-I, HTLV-II, HIV-1, and HIV-2].
Rasuli AM; Rasuli ShM; Klepikov NN; Andreev SM; Meshcheriakova DV; Tarasova SO; Seniuta NB; Syrtsev AV; Gurtsevich VE
Mol Biol (Mosk); 1995; 29(1):225-38. PubMed ID: 7723762
[TBL] [Abstract][Full Text] [Related]
14. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Suzuki J; Kira J; Baba E; Nakamura M; Koyanagi Y; Nakamura T; Kawano Y; Yamasaki K; Shirabe S; Hatano N; Hayashi K; Yamamoto N; Kobayashi T
J Infect Dis; 1996 May; 173(5):1115-22. PubMed ID: 8627062
[TBL] [Abstract][Full Text] [Related]
15. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
[TBL] [Abstract][Full Text] [Related]
16. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
[TBL] [Abstract][Full Text] [Related]
18. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of antibodies to human T-cell lymphotropic virus-I tax in patients with the cutaneous T-cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus.
Pancake BA; Wassef EH; Zucker-Franklin D
Blood; 1996 Oct; 88(8):3004-9. PubMed ID: 8874198
[TBL] [Abstract][Full Text] [Related]
20. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
